Michael F. Burgess

Insider Reports History

Location
Camridge, MA
Signature
/s/ P. Joseph Campisi, Jr., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael F. Burgess:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SpringWorks Therapeutics, Inc. Head of Research & Development Common Stock 49.6K $2.06M $41.53 18 Jul 2022 Direct
SpringWorks Therapeutics, Inc. Head of Research & Development Stock Option (Right to Buy) 48.9K 06 Jan 2022 Direct
SYNLOGIC, INC. Director Stock Option (right to buy) 30K 22 Jun 2023 Direct
Turnstone Biologics Corp. Interim Chief Medical Officer, Director Employee Stock Option (Right to Buy) 11.5K 16 Oct 2023 Direct

Insider Reports Filed by Michael F. Burgess

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TSBX Turnstone Biologics Corp. 16 Oct 2023 1 $0 4 Interim Chief Medical Officer, Director 17 Oct 2023, 18:37
TSBX Turnstone Biologics Corp. 20 Jul 2023 0 $0 3 Interim Chief Medical Officer, Director 20 Jul 2023, 21:48
SYBX SYNLOGIC, INC. 22 Jun 2023 1 $0 4 Director 26 Jun 2023, 14:21
SWTX SpringWorks Therapeutics, Inc. 18 Jul 2022 1 -$88.3K 4 Head of Research & Development 20 Jul 2022, 18:02
SYBX SYNLOGIC, INC. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 16:15
SWTX SpringWorks Therapeutics, Inc. 01 Jun 2022 2 -$52.4K 4 Head of Research & Development 05 Jul 2022, 17:29
SWTX SpringWorks Therapeutics, Inc. 06 Jan 2022 2 $0 4 Head of Research & Development 10 Jan 2022, 15:23
SYBX SYNLOGIC, INC. 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 17:12
SWTX SpringWorks Therapeutics, Inc. 01 Jun 2021 2 $0 4 Head of Research & Development 01 Jun 2021, 17:25
SWTX SpringWorks Therapeutics, Inc. 10 May 2021 0 $0 3 Head of Research & Development 10 May 2021, 16:30